Your browser doesn't support javascript.
loading
Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer.
Bruun, Jarle; Kolberg, Matthias; Ahlquist, Terje C; Røyrvik, Ellen C; Nome, Torfinn; Leithe, Edward; Lind, Guro E; Merok, Marianne A; Rognum, Torleiv O; Bjørkøy, Geir; Johansen, Terje; Lindblom, Annika; Sun, Xiao-Feng; Svindland, Aud; Liestøl, Knut; Nesbakken, Arild; Skotheim, Rolf I; Lothe, Ragnhild A.
Affiliation
  • Bruun J; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Kolberg M; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Ahlquist TC; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
  • Røyrvik EC; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Department of Molecular Biosciences, University of Oslo, Oslo, Norway. Department of Oncology, University of Oxford, ORCRB, Headington, Oxford, United Kingdom.
  • Nome T; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Leithe E; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Lind GE; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Merok MA; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Gastrointestinal Surgery, Aker Hospital-Oslo University Hospital, Oslo, Norway.
  • Rognum TO; Faculty of Medicine, University of Oslo, Norway. Division of Forensic Medicine, Department of Forensic Pathology and Clinical Forensic Medicine, the Norwegian Institute of Public Health, Oslo, Norway.
  • Bjørkøy G; University College of Sør-Trøndelag, Trondheim, Norway.
  • Johansen T; Molecular Cancer Research Group, Institute of Medical Biology, University of Tromsø, Tromsø, Norway.
  • Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
  • Sun XF; Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, County Council of Östergötland, University of Linköping, Linköping, Sweden.
  • Svindland A; Faculty of Medicine, University of Oslo, Norway. Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Liestøl K; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Informatics, Faculty of Mathematics and Natural Sciences, Oslo, Norway.
  • Nesbakken A; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Gastrointestinal Surgery, Aker Hospital-Oslo University Hospital, Oslo, Norway. Faculty of Medicine, University o
  • Skotheim RI; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Informa
  • Lothe RA; Department for Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Molecul
Clin Cancer Res ; 21(16): 3759-70, 2015 Aug 15.
Article in En | MEDLINE | ID: mdl-25910952
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosomal Proteins, Non-Histone / Colorectal Neoplasms / Biomarkers, Tumor / Guanine Nucleotide Exchange Factors / Microsatellite Instability Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Noruega
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosomal Proteins, Non-Histone / Colorectal Neoplasms / Biomarkers, Tumor / Guanine Nucleotide Exchange Factors / Microsatellite Instability Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Noruega